Metlife (MET-PE) Cash & Equivalents (2009 - 2026)

Metlife's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $11.2 billion for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 47.48% year-over-year to $11.2 billion; the TTM figure through Mar 2026 stood at $11.2 billion (down 47.48% YoY), while the FY2025 annual figure was $22.0 billion, up 85.14% from the prior year.
• Cash & Equivalents was $11.2 billion for Q1 2026 at Metlife, down from $22.0 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $23.5 billion in Q1 2022 to a low of $1.3 billion in Q4 2022.
• Historically, Cash & Equivalents has averaged $14.4 billion across 5 years, with a median of $12.0 billion in 2024.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents tumbled 70.8% in 2023, then soared 293.91% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $1.3 billion in 2022, then soared by 134.19% to $3.0 billion in 2023, then jumped by 293.91% to $11.9 billion in 2024, then soared by 85.14% to $22.0 billion in 2025, then tumbled by 49.16% to $11.2 billion in 2026.
• The last three Cash & Equivalents figures came in at $11.2 billion (Q1 2026), $22.0 billion (Q4 2025), and $20.2 billion (Q3 2025), per Business Quant data.